Abstract
End-stage heart disease can be a result of idiopathic cardiomyopathy, chronic ischemic damage or long-standing volume or pressure overload from valvular pathology. While cardiac transplantation may be the ultimate therapy for the fortunate patient who is eligible, conventional surgical interventions can be considered in highly selected cases. This chapter reviews the current evidence supporting the decision to provide high risk conventional surgery and summarizes the current indications and results of heart transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for Heart Transplantation: a 10 year update. J Heart Lung Transplant. 2016;35:1–23.
Kawajiri H, Manlhiot C, Ross H, et al. High risk cardiac surgery as an alternative to transplant or mechanical support in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2017;154:517–25.
Doenst T, Velazquez EJ, Beyersdorf F, et al. The STICH Investigators. To STICH or not TO STICH—We know the answer, but do we understand the question? J Thorac Cardiovasc Surg 2005; 129: 246-249
Jones RH, Velazquez EJ, Michler RE, et al. The STICH Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360:1705–1171
Velazquez EJ, Lee KL, Deja M, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607–16.
Velazquez EJ, Lee KL, Jones RH, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511–20.
Bonow RO, Maurer JG, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.
Panza JA, Holly TA, Asch FM, et al. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2013;61:1860–70.
Romano MA, Bolling SF. An update on mitral repair in dilated cardiomyopathy. J Card Surg. 2004;19:396–400.
Michler RE, Smith PK, Parides MK, et al. Two year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374:1932–41.
Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–35.
Athanasuleas CL, Buckberg GD, Stanley AW, et al. Surgical ventricular restoration: The Restore Group Experience. Heart Fail Rev. 2004;9:287–97.
Dor V, Saab M, Coste P, Kornaszewska M, Montiglio F. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg. 1989;37:11–9.
Mickleborough LL, Merchant N, Ivanov J, Rao V, Carson S. Left ventricular reconstruction: early and late results. J Thorac Cardiovasc Surg. 2004;128:27–37.
Michler RE, Rouleau JL, Al-Khalidi HR, et al. Insights from the STICH trial: change in ventricular size after coronary artery bypass grafting with or without surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2013;146:1139–45.
Dhital KK, Iyer A, Connellan M, et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series. Lancet. 2015;385:2585–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rao, V. (2021). Surgery for End-Stage Heart Disease and Heart Transplantation. In: Cheng, D.C., Martin, J., David, T. (eds) Evidence-Based Practice in Perioperative Cardiac Anesthesia and Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-47887-2_46
Download citation
DOI: https://doi.org/10.1007/978-3-030-47887-2_46
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-47886-5
Online ISBN: 978-3-030-47887-2
eBook Packages: MedicineMedicine (R0)